Hexobendine

Source: Wikipedia, the free encyclopedia.
Hexobendine
Clinical data
ATC code
Identifiers
  • Ethane-1,2-diylbis[(methylimino)propane-3,1-diyl] bis(3,4,5-trimethoxybenzoate)
JSmol)
  • COc1c(cc(cc1OC)C(=O)OCCCN(C)CCN(C)CCCOC(=O)c2cc(OC)c(OC)c(OC)c2)OC
  • InChI=1S/C30H44N2O10/c1-31(11-9-15-41-29(33)21-17-23(35-3)27(39-7)24(18-21)36-4)13-14-32(2)12-10-16-42-30(34)22-19-25(37-5)28(40-8)26(20-22)38-6/h17-20H,9-16H2,1-8H3 ☒N
  • Key:KRQAMFQCSAJCRH-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Hexobendine is a

vasodilator that acts as an adenosine reuptake inhibitor.[1]

Synthesis

Hexobendine can be synthesized starting with a reaction between 3,4,5-trimethoxybenzoyl chloride (1) and

3-chloropropanol (2) to give the corresponding ester, 3-chloropropyl 3,4,5-trimethoxybenzoate (3). The last step involves the reaction between two molar equivalents of 3 with one molar equivalent of 1,2-dimethylethylenediamine (4) completing the synthesis of hexobendine (5).[2][3]

Synthesis of hexobendine

See also

References

  1. PMID 1168469
    .
  2. ^ "Pharmaceutical Substances: Hexobendine". Thieme.
  3. ^ AT231432 idem Schlogl Karl, Kraupp Otto, U.S. patent 3,267,103 (1964 & 1966 to Chemie Linz Ag).